What this does NOT prove: Greater receptor availability at a longer duration does not automatically produce proportionally greater anabolic effect in humans
Asian J Neurosurg
Be Patient: Results may not be immediately visible, and it might take a few sessions to notice significant changes
While compounding during a shortage was a necessary solution, continuing to compound GLP-1s after the shortage has resolvedwithout a true, individualized clinical needis neither legal, ethical, nor in the best interest of patient safety. Dr
Fueling the Fire: Supply Shortages and the Compounded GLP-1s Demand for these potent medications has outpaced supply, particularly for specific dosages
The approval reflects FDAs continued openness to innovation in obesity treatment, including small-molecule alternatives to peptide-based drugs, even as the Agency sharpens its focus on how GLP-1 products and their alternatives are marketed